Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02181218
Title Phase I Study of Romidepsin, Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed/Refractory Aggressive Lymphomas
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Washington University School of Medicine
Indications

peripheral T-cell lymphoma

diffuse large B-cell lymphoma

Hodgkin's lymphoma

Therapies

Pegfilgrastim

Romidepsin

Dexamethasone + Gemcitabine + Oxaliplatin

Age Groups: adult
Covered Countries USA


No variant requirements are available.